| Primary |
| Product Used For Unknown Indication |
17.6% |
| Anaesthesia |
10.3% |
| Histiocytosis Haematophagic |
10.3% |
| Multiple Myeloma |
8.8% |
| Chemotherapy |
7.4% |
| Diffuse Large B-cell Lymphoma |
7.4% |
| Renal Impairment |
7.4% |
| Analgesic Therapy |
5.9% |
| Nerve Block |
5.9% |
| Arthritis |
4.4% |
| Prophylaxis |
2.9% |
| Prostate Cancer |
2.9% |
| Abdominal Pain |
1.5% |
| Acute Lymphocytic Leukaemia |
1.5% |
| Demyelinating Polyneuropathy |
1.5% |
| Drug Abuse |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Infection |
1.5% |
|
| Acute Promyelocytic Leukaemia |
13.3% |
| Anaphylactic Reaction |
13.3% |
| Thrombocytopenia |
13.3% |
| Acute Generalised Exanthematous Pustulosis |
6.7% |
| Guillain-barre Syndrome |
6.7% |
| Haemoglobin Decreased |
6.7% |
| Hyperglycaemia |
6.7% |
| Insomnia |
6.7% |
| Limb Discomfort |
6.7% |
| Mean Platelet Volume Decreased |
6.7% |
| Pituitary-dependent Cushing's Syndrome |
6.7% |
| Respiratory Distress |
6.7% |
|
| Secondary |
| Prophylaxis |
43.1% |
| Multiple Myeloma |
30.0% |
| Hypertension |
6.5% |
| Ill-defined Disorder |
4.5% |
| Diabetes Mellitus |
2.8% |
| Refractory Cancer |
2.6% |
| Constipation |
1.7% |
| Non-hodgkin's Lymphoma |
1.5% |
| Product Used For Unknown Indication |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Insomnia |
0.8% |
| Myeloma Recurrence |
0.7% |
| Prostate Cancer |
0.6% |
| Mantle Cell Lymphoma |
0.6% |
| Lymphoma |
0.5% |
| Osteoporosis |
0.4% |
| Angina Pectoris |
0.3% |
| Acute Myeloid Leukaemia |
0.3% |
| Cardiac Failure |
0.3% |
| Pneumonia |
0.3% |
|
| Platelet Count Decreased |
12.1% |
| Neutrophil Count Decreased |
9.0% |
| Blood Alkaline Phosphatase Increased |
7.9% |
| Diarrhoea |
7.2% |
| Osteonecrosis Of Jaw |
6.4% |
| Pain In Extremity |
6.2% |
| Rash |
6.2% |
| Pyrexia |
5.6% |
| Oedema |
5.4% |
| Anaemia |
5.1% |
| Dehydration |
4.6% |
| Interstitial Lung Disease |
3.3% |
| White Blood Cell Count Decreased |
3.1% |
| Febrile Neutropenia |
2.8% |
| Blood Creatinine Increased |
2.6% |
| Cystitis |
2.6% |
| Malaise |
2.6% |
| Neutropenia |
2.6% |
| Thrombocytopenia |
2.6% |
| Neuropathy Peripheral |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
13.9% |
| Multiple Myeloma |
13.2% |
| Prophylaxis |
10.3% |
| Hypertension |
8.3% |
| Pain |
6.3% |
| Product Used For Unknown Indication |
5.4% |
| Ill-defined Disorder |
5.2% |
| Stem Cell Transplant |
4.4% |
| Ovarian Cancer |
3.7% |
| Premedication |
3.7% |
| Non-small Cell Lung Cancer |
3.2% |
| Chemotherapy |
2.9% |
| Constipation |
2.8% |
| Depression |
2.8% |
| Nausea |
2.6% |
| Non-small Cell Lung Cancer Stage Iii |
2.6% |
| Back Pain |
2.3% |
| Breast Cancer |
2.2% |
| Colorectal Cancer |
2.2% |
| Glioblastoma Multiforme |
1.8% |
|
| Vomiting |
37.3% |
| Wound Drainage |
6.3% |
| Death |
5.6% |
| Hypersensitivity |
4.0% |
| Pneumonia |
4.0% |
| Pruritus |
4.0% |
| Renal Failure |
4.0% |
| Cardiopulmonary Failure |
3.2% |
| Dyspnoea |
3.2% |
| Pyrexia |
3.2% |
| Renal Failure Acute |
3.2% |
| Sepsis |
3.2% |
| Drug Interaction |
2.4% |
| Febrile Neutropenia |
2.4% |
| Osteonecrosis Of Jaw |
2.4% |
| Peripheral Sensory Neuropathy |
2.4% |
| Rash |
2.4% |
| Squamous Cell Carcinoma |
2.4% |
| Thrombocytopenia |
2.4% |
| Tongue Neoplasm Malignant Stage Unspecified |
2.4% |
|
| Interacting |
| Prophylaxis Of Nausea And Vomiting |
25.0% |
| Thyroglossal Cyst Excision |
25.0% |
| Induction And Maintenance Of Anaesthesia |
16.7% |
| Renal Cancer |
16.7% |
| Induction Of Anaesthesia |
8.3% |
| Product Used For Unknown Indication |
8.3% |
|
| Swelling |
50.0% |
| Ventricular Tachycardia |
50.0% |
|
